AEST.MED.INT.HLD.SP.ADR/3 (3FMA) — Financial Flexibility Index
AEST.MED.INT.HLD.SP.ADR/3 (3FMA) has a Financial Flexibility Index of -0.01x as of December 2025. Free cash flow of €-5.25 Million (operating CF €-12.23 Million minus capex €6.98 Million) represents 0% of total liabilities (€554.12 Million). Also explore 3FMA shareholders equity momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
AEST.MED.INT.HLD.SP.ADR/3 Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for AEST.MED.INT.HLD.SP.ADR/3 across 5 annual periods. Check 3FMA capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for AEST.MED.INT.HLD.SP.ADR/3 (2021–2025)
Year-by-year free cash flow to debt coverage for AEST.MED.INT.HLD.SP.ADR/3. For the full company profile including market capitalisation, see AEST.MED.INT.HLD.SP.ADR/3 (3FMA) total market value.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.01x | €-5.25 Million | €-12.23 Million | €554.12 Million | ▼ -104.1% |
| 2024 | 0.23x | €110.45 Million | €79.67 Million | €476.88 Million | ▼ -5.9% |
| 2023 | 0.25x | €129.75 Million | €74.29 Million | €527.03 Million | ▲ +325.3% |
| 2022 | -0.11x | €-73.45 Million | €-75.13 Million | €672.25 Million | ▼ -198.7% |
| 2021 | 0.11x | €84.53 Million | €51.09 Million | €763.36 Million | — |